Courvoisier Sign – Definition and Clinical Significance
The Courvoisier sign describes a painlessly enlarged gallbladder combined with jaundice – a key clinical indicator of malignant obstruction of the bile ducts.
Things worth knowing about "Courvoisier Sign"
The Courvoisier sign describes a painlessly enlarged gallbladder combined with jaundice – a key clinical indicator of malignant obstruction of the bile ducts.
What is the Courvoisier Sign?
The Courvoisier sign is a clinical finding identified during physical examination of the abdomen. It refers to the combination of a palpably enlarged, non-tender gallbladder and concurrent jaundice (icterus). The sign is named after the Swiss surgeon Ludwig Georg Courvoisier (1843–1918), who first systematically described this association.
In clinical medicine, the Courvoisier sign is considered an important diagnostic clue: a painless, distended gallbladder in the presence of jaundice most commonly suggests a malignant (cancerous) cause of bile duct obstruction – for example, pancreatic head carcinoma or cholangiocarcinoma.
Background and Pathophysiology
Under normal circumstances, chronic gallbladder disease – such as recurrent gallstones – causes the gallbladder wall to thicken, stiffen, and become fibrotic over time. If bile duct obstruction develops in such a setting, the scarred gallbladder cannot expand significantly.
In contrast, when obstruction is caused by a tumor compressing the bile duct from outside, the gallbladder wall is typically still pliable and unscarred. The accumulating bile is therefore able to distend the gallbladder considerably, making it palpable as a smooth, tense mass – without associated pain, as no inflammation is present.
This physiological principle forms the basis of the Courvoisier law: painless jaundice with a palpable gallbladder argues against gallstones and in favor of a malignant cause.
Causes and Associated Conditions
The Courvoisier sign is typically associated with the following conditions:
- Pancreatic head carcinoma: The most common cause; the tumor compresses the common bile duct as it passes through the head of the pancreas.
- Cholangiocarcinoma: Malignant tumor of the bile ducts causing obstruction to bile flow.
- Ampullary carcinoma: Tumor at the junction of the bile duct and the small intestine (ampulla of Vater).
- Lymph node compression: From lymphoma or metastatic disease compressing the bile duct.
- Rarely: Benign strictures or non-malignant external compression.
Clinical Relevance and Diagnosis
The Courvoisier sign is identified during abdominal physical examination. The examiner palpates a soft, tense, and non-tender mass in the right upper quadrant – the enlarged gallbladder.
Simultaneously, the patient presents with signs of obstructive jaundice: yellowing of the skin and eyes (scleral icterus), dark urine, pale (acholic) stools, and elevated liver function tests – particularly direct bilirubin, alkaline phosphatase, and GGT.
Further diagnostic workup typically includes:
- Abdominal ultrasound: First-line imaging to assess the gallbladder and bile ducts.
- CT or MRI of the abdomen: Detailed evaluation of the pancreas, biliary system, and potential tumors.
- MRCP (Magnetic Resonance Cholangiopancreatography): Non-invasive visualization of the bile and pancreatic ducts.
- ERCP (Endoscopic Retrograde Cholangiopancreatography): Allows both diagnosis and therapeutic intervention (e.g., stent placement).
- Tumor markers: CA 19-9 and CEA to support the diagnosis of malignancy.
Differential Diagnosis
Not all cases of jaundice are accompanied by the Courvoisier sign. Important differential diagnoses of obstructive jaundice without a palpable gallbladder include:
- Choledocholithiasis (bile duct stones) – the gallbladder is typically fibrotic and non-palpable due to chronic inflammation.
- Primary sclerosing cholangitis (PSC)
- Hepatitis and other hepatic causes of jaundice
- Hemolysis (pre-hepatic jaundice)
The Courvoisier sign helps differentiate malignant from benign obstructive jaundice. However, it is not an absolute sign and must always be interpreted within the broader clinical context.
Treatment
Treatment depends on the underlying cause. In the most common scenario – pancreatic head carcinoma – the following options are considered:
- Surgical resection: The Whipple procedure (pancreaticoduodenectomy) is the only potentially curative approach when the tumor is still resectable.
- Palliative biliary stenting: In non-resectable cases, a stent is placed in the bile duct to restore bile flow and relieve jaundice.
- Chemotherapy and radiotherapy: Used as adjuvant or palliative measures depending on the stage of disease.
- Supportive care: Nutritional support, pain management, and palliative care.
References
- Townsend, C. M. et al. – Sabiston Textbook of Surgery, 21st edition. Elsevier, 2022.
- Lau, W. Y. et al. – Carcinoma of the pancreas. British Journal of Surgery, 2016.
- Frossard, J. L. et al. – Courvoisier's sign revisited. European Journal of Gastroenterology and Hepatology, 2001.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Courvoisier Sign-en